Association between C-reactive protein and features of the metabolic syndrome

Diabetes Care

Volumn 23, Issue 12, 2000, Pages 1835-1839

  Fröhlich, Margit ^a,b   Imhof, Armin ^a   Berg, Gabriele ^b   Hutchinson, Winston L ^d   Pepys, Mark B ^d   Boeing, Heiner ^c   Muche, Rainer ^b   Brenner, Hermann ^b   Koenig, Wolfgang ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF ULM   (Germany)

^c German Institute for Human Nutrition   (Germany)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; GLUCOSE TOLERANCE; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; PROTEIN BLOOD LEVEL; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0033660004     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.12.1835     Document Type: Article

References (48)

1. Hyperinsulinaemia: The key feature of a cardiovascular and metabolic syndrome
2. Risk factor clustering in the insulin resistance syndrome: The Strong Heart Study
3. Relationships between fasting plasma insulin, anthropometrics, and metabolic parameters in a very old healthy population
4. Relation of components of insulin resistance syndrome to coronary disease risk
5. Hyperinsulinemia as an independent risk factor for ischemic heart disease
6. Familial components of the multiple metabolic syndrome: The ARIC Study
7. Genetic analysis of the IRS: Pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures
8. Adipose expression of tumor necrosis factor-α: Direct role in obesity-linked insulin resistance
9. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α in vivo
10. Role of cytokines in inducing hyperlipidemia
11. Tumor necrosis factor-α: A key component of the obesity-diabetes link
12. The acute phase response
13. Plasma fibrinogen: A new factor of the metabolic syndrome: A population-based study
14. PAI-1, obesity, insulin resistance and risk of cardiovascular events
15. Involvement of the hemostatic system in the insulin resistance syndrome: A study of 1,500 patients with angina pectoris
16. Whole-blood viscosity and the insulin-resistance syndrome
17. The white blood cell count: Its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals
18. Atherosclerosis: An inflammatory disease
19. Biology of disease: The pathogenesis of atherosclerosis: Atherogenesis and inflammation
20. Association of coronary plaque rupture and atherosclerotic inflammation
21. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies
22. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
23. White blood cell count and cardiovascular disease: Insights from the Framingham Study
24. Production of C-reactive protein and risk of coronary events in stable and unstable angina
25. Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: Results from the Cardiovascular Health Study and the Rural Health Promotion Project
26. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
27. Relation of C-reactive protein and coronary heart disease in the MRFIT nested casecontrol study
28. C-reactive protein (CRP) predicts risk of coronary heart disease (CHD) in healthy middle-aged men: Results from the MONICA-Augsburg cohort study, 1984-1992
29. Life-time smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and sublinical disease in healthy elderly subjects
30. C-reactive protein and its relation to cardiovascular risk factors: A population-based cross-sectional study
31. Risk factors for coronary heart disease and acute-phase proteins: A population-based study
32. A desktop guide for the management of non-insulin-dependent diabetes mellitus (NIDDM): An update
33. Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association
34. NIDDM as a disease of the innate immune system: Association of acute-phase reactants and interleukin-6 with metabolic syndrome X
35. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue?
36. Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects
37. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?
38. C-reactive protein: Binding to lipids and lipoproteins
39. CRP-mediated activation of complement in vivo: Assessment by measuring circulating complement-C-reactive protein-complexes
40. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor
41. How good a marker is insulin level for insulin resistance?
42. Insulin resistance and insulin secretory dysfuncion as precursors of non-insulin-dependent diabetes mellitus: Prospective studies of Pima Indians
43. Role of insulin resistance in human disease
44. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
45. Schatzung der diabeteshaufigkeit in der Bundesrepublik Deutschland anhand von krankenkassendaten: Sekundardatenanalyse einer reprasintativen Stichprobe AOK-Versicherter der Stadt Dortmund
46. Risk factor trends and cardiovascular mortality risk after 3.5 years of community-based intervention in the German Cardiovascular Prevention Study